Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response?

J Crohns Colitis. 2016 Mar;10(3):237-8. doi: 10.1093/ecco-jcc/jjv222. Epub 2015 Dec 8.

Authors

Marco Genua¹, Christoph Becker², Stefania Vetrano³

Affiliations

¹ IBD Center, Humanitas Research Hospital, Rozzano, Italy Department of Translational Medicine, Università degli Studi di Milano, Milan, Italy.
² Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
³ IBD Center, Humanitas Research Hospital, Rozzano, Italy Department of Biomedical Sciences, Humanitas University, Milan, Italy stefania.vetrano@humanitasreasearch.it.

No abstract available

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents / pharmacology*
Anti-Inflammatory Agents / therapeutic use
Antibodies, Monoclonal / pharmacology*
Antibodies, Monoclonal / therapeutic use
Autophagy / drug effects*
Autophagy / genetics
Autophagy / immunology
Genetic Predisposition to Disease
Humans
Inflammatory Bowel Diseases / drug therapy*
Inflammatory Bowel Diseases / genetics
Inflammatory Bowel Diseases / immunology
Precision Medicine
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / immunology

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha